(SNEX) Stonex - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8618961085
Stock: Financial Services, Trading, Payments, Metals
Total Rating 61
Risk 72
Buy Signal -0.49
| Risk 5d forecast | |
|---|---|
| Volatility | 37.2% |
| Relative Tail Risk | -2.72% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.10 |
| Alpha | 32.76 |
| Character TTM | |
|---|---|
| Beta | 0.982 |
| Beta Downside | 1.452 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.52% |
| CAGR/Max DD | 1.65 |
EPS (Earnings per Share)
Revenue
Description: SNEX Stonex March 05, 2026
StoneX Group Inc. (SNEX) operates as a diversified financial services company with a global presence, connecting various market participants. The companys business model spans commercial, institutional, retail, and payments segments, indicating a broad client base.
The Commercial segment focuses on risk management, hedging, and commodity services, including physical trading and financing. This segment also acts as an institutional dealer in fixed income securities, a core activity within investment banking.
The Self-Directed/Retail segment offers trading services in global financial markets, including foreign exchange and precious metals, and provides wealth management. Retail brokerage services often involve high transaction volumes.
For more detailed financial analysis, consider exploring ValueRays comprehensive data on SNEX.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 359.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 8.08 > 1.0 |
| NWC/Revenue: 10.04% < 20% (prev 8.41%; Δ 1.63% < -1%) |
| CFO/TA 0.08 > 3% & CFO 3.62b > Net Income 359.8m |
| Net Debt (18.65b) to EBITDA (2.20b): 8.48 < 3 |
| Current Ratio: 1.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (53.7m) vs 12m ago 10.25% < -2% |
| Gross Margin: 2.01% > 18% (prev 0.02%; Δ 198.6% > 0.5%) |
| Asset Turnover: 370.9% > 50% (prev 365.9%; Δ 4.98% > 0%) |
| Interest Coverage Ratio: 1.29 > 6 (EBITDA TTM 2.20b / Interest Expense TTM 1.65b) |
Altman Z'' 2.51
| A: 0.30 (Total Current Assets 35.82b - Total Current Liabilities 21.41b) / Total Assets 47.78b |
| B: 0.04 (Retained Earnings 1.83b / Total Assets 47.78b) |
| C: 0.05 (EBIT TTM 2.12b / Avg Total Assets 38.68b) |
| D: 0.04 (Book Value of Equity 1.82b / Total Liabilities 45.26b) |
| Altman-Z'' Score: 2.51 = A |
Beneish M -2.92
| DSRI: 0.96 (Receivables 11.33b/8.90b, Revenue 143.47b/108.25b) |
| GMI: 0.98 (GM 2.01% / 1.97%) |
| AQI: 0.98 (AQ_t 0.24 / AQ_t-1 0.25) |
| SGI: 1.33 (Revenue 143.47b / 108.25b) |
| TATA: -0.07 (NI 359.8m - CFO 3.62b) / TA 47.78b) |
| Beneish M-Score: -2.92 (Cap -4..+1) = A |
What is the price of SNEX shares?
As of March 06, 2026, the stock is trading at USD 119.56 with a total of 397,127 shares traded.
Over the past week, the price has changed by -8.70%, over one month by +5.29%, over three months by +28.02% and over the past year by +49.18%.
Over the past week, the price has changed by -8.70%, over one month by +5.29%, over three months by +28.02% and over the past year by +49.18%.
Is SNEX a buy, sell or hold?
Stonex has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy SNEX.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SNEX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 135 | 12.9% |
| Analysts Target Price | 135 | 12.9% |
SNEX Fundamental Data Overview March 06, 2026
P/E Trailing = 18.4149
P/E Forward = 9.7943
P/S = 0.0456
P/B = 2.6034
Revenue TTM = 143.47b USD
EBIT TTM = 2.12b USD
EBITDA TTM = 2.20b USD
Long Term Debt = 19.55b USD (from longTermDebt, last quarter)
Short Term Debt = 488.8m USD (from shortTermDebt, last quarter)
Debt = 20.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.65b USD (from netDebt column, last quarter)
Enterprise Value = 25.12b USD (6.47b + Debt 20.24b - CCE 1.59b)
Interest Coverage Ratio = 1.29 (Ebit TTM 2.12b / Interest Expense TTM 1.65b)
EV/FCF = 7.07x (Enterprise Value 25.12b / FCF TTM 3.55b)
FCF Yield = 14.15% (FCF TTM 3.55b / Enterprise Value 25.12b)
FCF Margin = 2.48% (FCF TTM 3.55b / Revenue TTM 143.47b)
Net Margin = 0.25% (Net Income TTM 359.8m / Revenue TTM 143.47b)
Gross Margin = 2.01% ((Revenue TTM 143.47b - Cost of Revenue TTM 140.60b) / Revenue TTM)
Gross Margin QoQ = 2.29% (prev 2.27%)
Tobins Q-Ratio = 0.53 (Enterprise Value 25.12b / Total Assets 47.78b)
Interest Expense / Debt = 2.41% (Interest Expense 488.0m / Debt 20.24b)
Taxrate = 24.82% (45.9m / 184.9m)
NOPAT = 1.60b (EBIT 2.12b * (1 - 24.82%))
Current Ratio = 1.67 (Total Current Assets 35.82b / Total Current Liabilities 21.41b)
Debt / Equity = 8.03 (Debt 20.24b / totalStockholderEquity, last quarter 2.52b)
Debt / EBITDA = 8.48 (Net Debt 18.65b / EBITDA 2.20b)
Debt / FCF = 5.25 (Net Debt 18.65b / FCF TTM 3.55b)
Total Stockholder Equity = 2.19b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.93% (Net Income 359.8m / Total Assets 47.78b)
RoE = 16.43% (Net Income TTM 359.8m / Total Stockholder Equity 2.19b)
RoCE = 9.77% (EBIT 2.12b / Capital Employed (Equity 2.19b + L.T.Debt 19.55b))
RoIC = 8.24% (NOPAT 1.60b / Invested Capital 19.36b)
WACC = 3.68% (E(6.47b)/V(26.72b) * Re(9.53%) + D(20.24b)/V(26.72b) * Rd(2.41%) * (1-Tc(0.25)))
Discount Rate = 9.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.95%
[DCF] Terminal Value 80.82% ; FCFF base≈3.55b ; Y1≈2.33b ; Y5≈1.06b
[DCF] Fair Price = 291.0 (EV 33.92b - Net Debt 18.65b = Equity 15.27b / Shares 52.5m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -69.71 | EPS CAGR: -5.66% | SUE: 3.74 | # QB: 1
Revenue Correlation: 90.17 | Revenue CAGR: 26.05% | SUE: 1.54 | # QB: 10
EPS next Quarter (2026-06-30): EPS=1.83 | Chg7d=+1.830 | Chg30d=+1.830 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-09-30): EPS=8.31 | Chg7d=+0.780 | Chg30d=+0.780 | Revisions Net=+1 | Growth EPS=+38.0% | Growth Revenue=+0.0%
EPS next Year (2027-09-30): EPS=8.78 | Chg7d=+0.240 | Chg30d=+0.240 | Revisions Net=+1 | Growth EPS=+5.7% | Growth Revenue=+0.0%
P/E Forward = 9.7943
P/S = 0.0456
P/B = 2.6034
Revenue TTM = 143.47b USD
EBIT TTM = 2.12b USD
EBITDA TTM = 2.20b USD
Long Term Debt = 19.55b USD (from longTermDebt, last quarter)
Short Term Debt = 488.8m USD (from shortTermDebt, last quarter)
Debt = 20.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.65b USD (from netDebt column, last quarter)
Enterprise Value = 25.12b USD (6.47b + Debt 20.24b - CCE 1.59b)
Interest Coverage Ratio = 1.29 (Ebit TTM 2.12b / Interest Expense TTM 1.65b)
EV/FCF = 7.07x (Enterprise Value 25.12b / FCF TTM 3.55b)
FCF Yield = 14.15% (FCF TTM 3.55b / Enterprise Value 25.12b)
FCF Margin = 2.48% (FCF TTM 3.55b / Revenue TTM 143.47b)
Net Margin = 0.25% (Net Income TTM 359.8m / Revenue TTM 143.47b)
Gross Margin = 2.01% ((Revenue TTM 143.47b - Cost of Revenue TTM 140.60b) / Revenue TTM)
Gross Margin QoQ = 2.29% (prev 2.27%)
Tobins Q-Ratio = 0.53 (Enterprise Value 25.12b / Total Assets 47.78b)
Interest Expense / Debt = 2.41% (Interest Expense 488.0m / Debt 20.24b)
Taxrate = 24.82% (45.9m / 184.9m)
NOPAT = 1.60b (EBIT 2.12b * (1 - 24.82%))
Current Ratio = 1.67 (Total Current Assets 35.82b / Total Current Liabilities 21.41b)
Debt / Equity = 8.03 (Debt 20.24b / totalStockholderEquity, last quarter 2.52b)
Debt / EBITDA = 8.48 (Net Debt 18.65b / EBITDA 2.20b)
Debt / FCF = 5.25 (Net Debt 18.65b / FCF TTM 3.55b)
Total Stockholder Equity = 2.19b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.93% (Net Income 359.8m / Total Assets 47.78b)
RoE = 16.43% (Net Income TTM 359.8m / Total Stockholder Equity 2.19b)
RoCE = 9.77% (EBIT 2.12b / Capital Employed (Equity 2.19b + L.T.Debt 19.55b))
RoIC = 8.24% (NOPAT 1.60b / Invested Capital 19.36b)
WACC = 3.68% (E(6.47b)/V(26.72b) * Re(9.53%) + D(20.24b)/V(26.72b) * Rd(2.41%) * (1-Tc(0.25)))
Discount Rate = 9.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.95%
[DCF] Terminal Value 80.82% ; FCFF base≈3.55b ; Y1≈2.33b ; Y5≈1.06b
[DCF] Fair Price = 291.0 (EV 33.92b - Net Debt 18.65b = Equity 15.27b / Shares 52.5m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -69.71 | EPS CAGR: -5.66% | SUE: 3.74 | # QB: 1
Revenue Correlation: 90.17 | Revenue CAGR: 26.05% | SUE: 1.54 | # QB: 10
EPS next Quarter (2026-06-30): EPS=1.83 | Chg7d=+1.830 | Chg30d=+1.830 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-09-30): EPS=8.31 | Chg7d=+0.780 | Chg30d=+0.780 | Revisions Net=+1 | Growth EPS=+38.0% | Growth Revenue=+0.0%
EPS next Year (2027-09-30): EPS=8.78 | Chg7d=+0.240 | Chg30d=+0.240 | Revisions Net=+1 | Growth EPS=+5.7% | Growth Revenue=+0.0%